Acalabrutinib

Specifications

1420477-60-6CAS Number

814-272-0EC Number

4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamideIUPAC Name

C26H23N7O2Chemical Formula

465.5 g/molMolecular Weight

Acalabrutinib; 1420477-60-6; ACP-196; acalabrutinibum; I42748ELQW; 4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide; Benzamide, 4-[8-amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinyl-; CHEBI:167707; DTXSID401026209; 4-[8-Amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinylbenzamide; 4-{8-amino-3-[(2S)-1-(but-2-ynoyl)pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl}-N-(pyridin-2-yl)benzamide; Benzamide, 4-(8-amino-3-((2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl)imidazo(1,5-a)pyrazin-1-yl)-N-2-pyridinyl-; 4-(8-Amino-3-((2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl)imidazo(1,5-a)pyrazin-1-yl)-N-2-pyridinylbenzamide; 4-(8-amino-3-((2S)-1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo(1,5-a)pyrazin-1-yl)-N-(pyridin-2-yl)benzamide; 4-(8-amino-3-((2S)-1-but-2-ynoylpyrrolidin-2-yl)imidazo(1,5-a)pyrazin-1-yl)-N-pyridin-2-ylbenzamide; RefChem:57414; L01XE51; DTXCID401510462; Bruton Tyrosine Kinase Inhibitor ACP-196; 814-272-0; Calquence; Acalabrutinib (ACP-196); Acalabrutinib [INN]; MFCD29472294; (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide; Acalabrutinib(ACP196); Calquence (TN); 4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-(2-pyridyl)benzamide; Acalabrutinib [USAN:INN]; UNII-I42748ELQW; C26H23N7O2; 4-[8-amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinylbenzamide; ACP 196; Acalabrutinib (Standard); ACP-196;Acalabrutinib; ACALABRUTINIB [MI]; ACALABRUTINIB [JAN]; ACALABRUTINIB [USAN]; ACALABRUTINIB [WHO-DD]; ACP196; GTPL8912; orb1226320; orb1303984; Acalabrutinib (JAN/USAN/INN); CHEMBL3707348; SCHEMBL14637368; SCHEMBL29376537; ACP 196; EX-A881; WDENQIQQYWYTPO-IBGZPJMESA-N; BDBM737806; GLXC-90498; ACALABRUTINIB [ORANGE BOOK]; (S)-4-(8-amino-3-(1-but-2-ynoylpyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide; BDBM50175583; EBC-17121; HY-17600R; NSC791164; NSC800976; s8116; AKOS030526094; CCG-269407; CS-5356; DB11703; DS-3326; NSC-791164; NSC-800976; US12291534, Compound Acalabrutinib; NCGC00479074-01; NCGC00479074-02; BP-43623; FA138815; HY-17600; SY099670; Example 6 [US20140155385 A1]; NS00073620; D10893; EN300-7369651; A081014; BRD-K64034691-001-01-9; Q23668732; Z2238902271; 4-{8-Amino-3-[(2S)-1-(2-butynoyl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl}-N-(2-pyridinyl)benzamideSynonyms